Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Nine months to progression using fourth-line liposomally encapsulated paclitaxel against hepatocellular carcinoma.

Christopeit M, Lenz G, Forstpointner R, Bartelheim K, Kühnbach R, Naujoks K, Schalhorn A.

Chemotherapy. 2008;54(4):309-14. doi: 10.1159/000151352. Epub 2008 Aug 14.

PMID:
18701819
2.

Morphology and transfection study of human microvascular endothelial cell angiogenesis: an in vitro three-dimensional model.

Lienau J, Kaletta C, Teifel M, Naujoks K, Bhoola K, Plendl J.

Biol Chem. 2005 Feb;386(2):167-75.

PMID:
15843161
3.

Endostatin cDNA/cationic liposome complexes as a promising therapy to prevent lung metastases in osteosarcoma: study in a human-like rat orthotopic tumor.

Dutour A, Monteil J, Paraf F, Charissoux JL, Kaletta C, Sauer B, Naujoks K, Rigaud M.

Mol Ther. 2005 Feb;11(2):311-9.

4.

Protamine enhances uptake of cationic liposomes in angiogenic microvessels.

Eichhorn ME, Strieth S, Krasnici S, Sauer B, Teifel M, Michaelis U, Naujoks K, Dellian M.

Angiogenesis. 2004;7(2):133-41.

PMID:
15516834
5.

Targeting diphtheria toxin A-chain transcription to activated endothelial cells using an E-selectin promoter.

Maxwell IH, Kaletta C, Naujoks K, Maxwell F.

Angiogenesis. 2003;6(1):31-8.

PMID:
14517402
6.

Neovascular targeting therapy: paclitaxel encapsulated in cationic liposomes improves antitumoral efficacy.

Schmitt-Sody M, Strieth S, Krasnici S, Sauer B, Schulze B, Teifel M, Michaelis U, Naujoks K, Dellian M.

Clin Cancer Res. 2003 Jun;9(6):2335-41.

7.

Effect of the surface charge of liposomes on their uptake by angiogenic tumor vessels.

Krasnici S, Werner A, Eichhorn ME, Schmitt-Sody M, Pahernik SA, Sauer B, Schulze B, Teifel M, Michaelis U, Naujoks K, Dellian M.

Int J Cancer. 2003 Jul 1;105(4):561-7.

8.

Paclitaxel encapsulated in cationic liposomes diminishes tumor angiogenesis and melanoma growth in a "humanized" SCID mouse model.

Kunstfeld R, Wickenhauser G, Michaelis U, Teifel M, Umek W, Naujoks K, Wolff K, Petzelbauer P.

J Invest Dermatol. 2003 Mar;120(3):476-82.

9.

[Induction of antitumor immune response in the mouse model after vaccination with B7.1 expressing tumor cells].

Wollenberg B, Lang S, Friess T, Naujoks K, Mayer A, Kastenbauer E, Zeidler R.

Laryngorhinootologie. 1999 Jan;78(1):36-40. German.

PMID:
10080127
10.

Gene therapy--phase I trial for primary untreated head and neck squamous cell cancer (HNSCC) UICC stage II-IV with a single intratumoral injection of hIL-2 plasmids formulated in DOTMA/Chol.

Wollenberg B, Kastenbauer, Mundl H, Schaumberg J, Mayer A, Andratschke M, Lang S, Pauli C, Zeidler R, Ihrler S, Löhrs, Naujoks K, Rollston R.

Hum Gene Ther. 1999 Jan 1;10(1):141-7.

PMID:
10022539
11.

Lipofection of cultured mouse muscle cells: a direct comparison of Lipofectamine and DOSPER.

Dodds E, Dunckley MG, Naujoks K, Michaelis U, Dickson G.

Gene Ther. 1998 Apr;5(4):542-51.

12.

Regional, developmental and interspecies expression of the four NMDAR2 subunits, examined using monoclonal antibodies.

Laurie DJ, Bartke I, Schoepfer R, Naujoks K, Seeburg PH.

Brain Res Mol Brain Res. 1997 Nov;51(1-2):23-32.

PMID:
9427503
13.

Evidence for safety and efficacy of DOTAP cationic liposome mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis.

Porteous DJ, Dorin JR, McLachlan G, Davidson-Smith H, Davidson H, Stevenson BJ, Carothers AD, Wallace WA, Moralee S, Hoenes C, Kallmeyer G, Michaelis U, Naujoks K, Ho LP, Samways JM, Imrie M, Greening AP, Innes JA.

Gene Ther. 1997 Mar;4(3):210-8.

14.

Laboratory and clinical studies in support of cystic fibrosis gene therapy using pCMV-CFTR-DOTAP.

McLachlan G, Ho LP, Davidson-Smith H, Samways J, Davidson H, Stevenson BJ, Carothers AD, Alton EW, Middleton PG, Smith SN, Kallmeyer G, Michaelis U, Seeber S, Naujoks K, Greening AP, Innes JA, Dorin JR, Porteous DJ.

Gene Ther. 1996 Dec;3(12):1113-23.

PMID:
8986438
15.

[Somatic gene therapy in squamous epithelial carcinomas of the head-neck area].

Wollenberg B, Naujoks K, Kastenbauer E.

Laryngorhinootologie. 1996 Jun;75(6):356-62. Review. German.

PMID:
8766383
16.

Characterization of mono- and polyclonal antibodies against highly purified choline acetyltransferase: a monoclonal antibody shows reactivity in human brain.

Ostermann-Latif C, Mäder M, Unger JW, Bartke I, Naujoks K, Peters JH, Felgenhauer K.

J Neurochem. 1992 Mar;58(3):1060-5.

PMID:
1737984
17.

A monoclonal antibody that specifically inhibits human salivary alpha-amylase.

Gerber M, Naujoks K, Lenz H, Wulff K.

Clin Chem. 1987 Jul;33(7):1158-62.

18.

Specific immunoassay of alpha-amylase isoenzymes in human serum.

Gerber M, Naujoks K, Lenz H, Gerhardt W, Wulff K.

Clin Chem. 1985 Aug;31(8):1331-4.

20.

Biological and immunological properties of the nerve growth factor from bovine seminal plasma: comparison with the properties of mouse nerve growth factor.

Harper GP, Barde YA, Edgar D, Ganten D, Hefti F, Heumann R, Naujoks KW, Rohrer H, Turner JE, Thoenen H.

Neuroscience. 1983;8(2):375-87. No abstract available.

PMID:
6133237
21.

Supplemental Content

Loading ...
Support Center